Myocardial InfarctionNCT07138911
Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity
A study testing Intervention group in people with Myocardial Infarction and Kinesiophobia, run by Riphah International University at 1 site in Pakistan.
Trial summary
To evaluate the effect of home-based exercise plan mediated by a digital health application on kinesiophobia and functional capacity in sedentary post myocardial infarction patients. Read more about this study
- Who is it for?
- Ages 30 to 55 years
- Conditions the study is for
- Myocardial Infarction, Kinesiophobia, Sedentary Behavior
- What is being tested?
- Intervention group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 88 participants
- Where
- 1 sitePakistan
- Study dates
- 13 Aug 2025to 25 Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 3 months post myocardial infarction patient
- Sitting hours >8
- IPAQ < 600 Mets minutes
Who cannot join
- Unstable Angina
- Recurrent Myocardial infarction
- Recent surgery or Procedure
- Heart failure, Arrhythmia
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Polyclinic Hospital
Islamabad, Federal, 45300
Mehwish Waseem, MS-CPPT PhD*, 0331-5309015, mehwish.waseem@riphah.edu.pk
Noureen Begum, MSPT-CPPT*, 0320 5609954, knoureen79@gmail.com
About this study
Official title: Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity in Sedentary Post Myocardial Infarction Patient.
To evaluate the effect of home-based exercise plan mediated by a digital health application on kinesiophobia and functional capacity in sedentary post myocardial infarction patients. Evidence suggest that digital health application significantly improve physical activity level in patient following cardiac event by providing personalized exercise plan, real time feed back, progress tracking and motivational features which enhanced adherence and engagement in rehabilitation program. This study could offer a viable le solution for overcoming barrier to rehabilitation particularly for those unable to access traditional clinic-based program
Read the detailed description
Mobile health (m health) strategies to increase adherence to physical activity is a promising approach. Mobile technology has become more integrated with health care and use of mobile health apps has become feasible for even the most novice users. Mobile health app can be effective adjuncts for the management of chronic condition and have a positive impact on long term behavior. The mobile health app promote the physical activity maintenance after cardiac rehabilitation. Recently, researchers have stated that mobile health intervention promoting the physical activity in the patient of cardiovascular disease. Mobile health intervention promote physical activity and daily step count after completing cardiac rehab.
- Conditions
- Myocardial Infarction, Kinesiophobia, Sedentary Behavior
- Being tested
- Intervention group, Control group
- Keywords
- Digital health app, Functional capacity, Kinesiophobia, Myocardial Infarction, Sedentary
- Medical subject headings
- Myocardial Infarction, Kinesiophobia, Sedentary Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention groupOther
Walking at home for 15-30 minutes 3 times per day for 4 weeks. Activity plan is calendar on mobile health app. Mobile placed in pocket or bag before starting walk and mark activity on calendar.
Control groupOther
Walking at home for 15-30 minutes 3 times per day for 4 weeks. Manual record of walking and date.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Home based exercise plan mediated by use of mobile health app Receives: Other: Intervention group |
| Control Group | Active comparator | Home based exercise plan Receives: Other: Control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Kinesiophobia
Changes from baseline to 4 weeks after intervention, measured through the TSK-SV Heart specifically focuses on assessing Kinesiophobia in the context of cardiac conditions or symptoms. It include questions related to fear of engaging in physical activity due to concerns about cardiac events (such as heart palpitations, chest pain, or shortness of breath) during exercise or daily activities. The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible Kinesiophobia, and the higher scores indicate an increasing degree of Kinesiophobia.
Measured: 4 Weeks
Functional Capacity
Changes from baseline to 4 weeks after intervention, measured through six minute walk test which is a sub-maximal exercise test used to assess functional capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Measured: 4 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2025
- Study start13 Aug 2025
- Primary completion20 Feb 2026 (estimated)
- Study completion25 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 88 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mehwish Waseem, MS-CPPT PhD*, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07138911
- Sponsor's protocol ID
- REC/MS-PT/ 02224 Noureen Begum
- Status last verified
- Feb 2026
- First submitted
- 18 Aug 2025
- Last updated
- 25 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity in Sedentary Post Myocardial Infarction Patient.
- ClinicalTrials.gov ID
- NCT07138911
- Acronym / sponsor ID
- REC/MS-PT/ 02224 Noureen Begum
- Conditions
- Myocardial Infarction, Kinesiophobia, Sedentary Behavior
- Keywords
- Digital health app, Functional capacity, Kinesiophobia, Myocardial Infarction, Sedentary
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 88 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 13 Aug 2025 (actual)
- Primary completion
- 20 Feb 2026 (estimated)
- Study completion
- 25 Feb 2026 (estimated)
- First posted
- 24 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the effect of home-based exercise plan mediated by a digital health application on kinesiophobia and functional capacity in sedentary post myocardial infarction patients. Evidence suggest that digital health application significantly improve physical activity level in patient following cardiac event by providing personalized exercise plan, real time feed back, progress tracking and motivational features which enhanced adherence and engagement in rehabilitation program. This study could offer a viable le solution for overcoming barrier to rehabilitation particularly for those unable to access traditional clinic-based program
Detailed description
Mobile health (m health) strategies to increase adherence to physical activity is a promising approach. Mobile technology has become more integrated with health care and use of mobile health apps has become feasible for even the most novice users. Mobile health app can be effective adjuncts for the management of chronic condition and have a positive impact on long term behavior. The mobile health app promote the physical activity maintenance after cardiac rehabilitation. Recently, researchers have stated that mobile health intervention promoting the physical activity in the patient of cardiovascular disease. Mobile health intervention promote physical activity and daily step count after completing cardiac rehab.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Other: Intervention groupHome based exercise plan mediated by use of mobile health app |
| Control Group | Active comparator | Other: Control groupHome based exercise plan |
Who may qualify
- Ages
- 30 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- 3 months post myocardial infarction patient
- Sitting hours >8
- IPAQ < 600 Mets minutes
Key exclusion criteria (4 listed)
- Unstable Angina
- Recurrent Myocardial infarction
- Recent surgery or Procedure
- Heart failure, Arrhythmia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention groupWalking at home for 15-30 minutes 3 times per day for 4 weeks. Activity plan is calendar on mobile health app. Mobile placed in pocket or bag before starting walk and mark activity on calendar. | Other | Intervention group |
| Control groupWalking at home for 15-30 minutes 3 times per day for 4 weeks. Manual record of walking and date. | Other | Control Group |
Primary outcome
Kinesiophobia
Time frame: 4 Weeks
Changes from baseline to 4 weeks after intervention, measured through the TSK-SV Heart specifically focuses on assessing Kinesiophobia in the context of cardiac conditions or symptoms. It include questions related to fear of engaging in physical activity due to concerns about cardiac events (such as heart palpitations, chest pain, or shortness of breath) during exercise or daily activities. The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible Kinesiophobia, and the higher scores indicate an increasing degree of Kinesiophobia.
Functional Capacity
Time frame: 4 Weeks
Changes from baseline to 4 weeks after intervention, measured through six minute walk test which is a sub-maximal exercise test used to assess functional capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Myocardial Infarction
RecruitingPhase 4
Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction
ST Elevation Myocardial Infarction
Not yet recruitingPhase 4
Capital Offload-Shock
Hypervolemia, Cardiogenic Shock
Recruiting
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
Myocardial Infarction (MI), Sudden Cardiac Death Due to Cardiac Arrhythmia
Recruiting
CRP Apheresis in Infarct-Related Cardiogenic Shock
Cardiogenic Shock, Acute Myocardial Infarction (AMI)
RecruitingObservational study
Breisgau PHENO-HEART MI
Myocardial Infarction, STEMI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mehwish Waseem, MS-CPPT PhD* principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention group in people with Myocardial Infarction and Kinesiophobia, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mehwish Waseem, MS-CPPT PhD* (0331-5309015, mehwish.waseem@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Kinesiophobia (time frame: 4 Weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.